ABVC BioPharma Provides ADHD Phase II Part 2 Clinical Update
Go back to ABVC BioPharma Provides ADHD Phase II Part 2 Clinical Update| (NASDAQ: ABVC) | Delayed: 0.93 -0.03 (3.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.96 | 52 Week High | $25.00 | |||
| Open | $0.97 | 52 Week Low | $1.00 | |||
| Day High | $0.98 | P/E | N/A | |||
| Day Low | $0.89 | EPS | $0.00 | |||
| Volume | 73,772 | |||||

